What You Should Know:
- MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today.
- The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services.
MedTech
Breakthrough, a market intelligence organization that
Read More
The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health
What You Should Know:
- DNA Company acquires AI-based digital therapeutics app My Pain Sensei (MPS) to form My Next Health and is building a COVID-19 risk assessment platform to help people understand their risks of developing serious COVID-19 complications.
- The acquisition combines functional genomics with conversational AI for patient self-management apps and disease tracking tools designed to inform clinician-patient interactions.
Leading functional genomics provider The
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
Natalie LaFranzo, Ph.D. is VP, Market Development of Cofactor Genomics
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event,
Read More
In-Depth: 32 FDA-Approved COVID-19 Testing Kits
What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
Intel Launches $50M Pandemic Response Technology Initiative to Combat Coronavirus
What You Should Know:
- Intel pledges an additional $50 million in a pandemic response technology initiative to combat the coronavirus through accelerating access to technology at the point of patient care.
- Intel is committed to accelerating access to technology that can combat the current COVID-19 pandemic and enable new technology and the scientific discovery that better prepares society for future crises.
Intel is pledging an additional $50 million in a pandemic response
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is
Read More
The Many Faces of AI in Clinical Trials
Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and
Read More
Life Image Launches Network Build to Help Providers Build Large-Scale Patient Data Networks
- Life Image launches Network Build Enterprise Solution to help healthcare organizations establish their own network connections to coordinate care and innovate. - Network Build allows healthcare organizations to create customized medical networks that can handle intensive data (e.g. diagnostic images, pathology, genomics, etc.) critical for advancing medical device development, clinical trials and more.Life Image, the world’s largest medical evidence network for clinical and imaging data,
Read More
Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology
- Together, PGDx and Mayo Clinic will focus on technology optimization and clinical utility studies for liquid biopsy and tissue-based genomic applications.- The shared vision and overall goal for PGDx and Mayo Clinic is to improve patient care by advancing the capabilities of oncology diagnostics testing. Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of clinical diagnostic solutions for
Read More
Health Data Privacy: Why Eroding Public Trust Harms Medical Research
Scott Kahn, Ph.D, Chief Information Officer at LunaPBC
Using Data Privacy to Empower Health Research
The importance of data security and data privacy policies have recently come under scrutiny due to revelations around Google’s Project Nightingale. The initiative with Ascension, the nation’s largest nonprofit health system, granted Google access to medical records of more than 50 million individuals in 21 states and may hinder the trajectory of health discovery by eroding “consumer”
Read More
